Recruiting Thrombocytopenia Studies in Philadelphia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a low number of platelets, making it ...
A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
The purpose of this study is to evaluate the efficacy and safety of VLX-1005, a 12-lipoxygenase (12-LOX) enzyme inhibitor in treating heparin induced thrombocytopenia (HIT). Participants with suspecte...
About Thrombocytopenia Clinical Trials in Philadelphia
Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.
There are currently 2 thrombocytopenia clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 231 participants. Research is being sponsored by Takeda, Veralox Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thrombocytopenia Clinical Trials in Philadelphia — FAQ
Are there thrombocytopenia clinical trials in Philadelphia?
Yes, there are 2 thrombocytopenia clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What thrombocytopenia treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.
Data updated March 2, 2026 from ClinicalTrials.gov